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ABSTRACT
p16
INK4a and p21
WAF1, two major cyclin-dependent
kinase inhibitors, are the products of two tumor
suppressor genes that play important roles in
various cellular metabolic pathways. p21
WAF1 is up-
regulated in response to different DNA damaging
agents. While the activation of p21
WAF1 is p53-
dependent following g-rays, the effect of ultraviolet
(UV) light on p21
WAF1 protein level is still unclear. In
the present report, we show that the level of the
p21
WAF1 protein augments in response to low UVC
fluences in different mammalian cells. This up-
regulation is mediated through the stabilization of
p21
WAF1 mRNA in a p16
INK4a-dependent manner in
both human and mouse cells. Furthermore, using
p16-siRNA treated human skin fibroblast; we have
shown that p16 controls the UV-dependent cytoplas-
mic accumulation of the mRNA binding HuR protein.
In addition, HuR immunoprecipitations showed that
UV-dependent binding of HuR to p21 mRNA is
p16-related. This suggests that p16 induces p21 by
enabling the relocalization of HuR from the nucleus
to the cytoplasm. Accordingly, we have also shown
that p16 is necessary for efficient UV-dependent p53
up-regulation, which also requires HuR. These
results indicate that, in addition to its role in cell
proliferation, p16
INK4a is also an important regulator
of the cellular response to UV damage.
INTRODUCTION
Eukaryotic organisms are under continuous stress of environ-
mental as well as intracellular origins. The cellular response
to these stresses is complex and involves different metabolic
pathways. These include the activation of a battery of genes
that guarantee efﬁcient repair and impose a tight negative
regulation on the progression of the cell cycle, in order to
prevent premature entry of the cell with damaged DNA into
the next phase (1). These delays of cellular proliferation at
speciﬁc stages, called cell cycle checkpoints, integrate DNA
repair with cell cycle progression through a network of genes
and pathways (2). Many of these genes are mutated in a broad
range of human cancers, which reveals their pivotal role in
the cellular defense against neoplastic transformation. The
function of the major tumor suppressor genes is to inhibit
the action of speciﬁc cyclin-dependant kinases (CDK),
whose oscillations in activity play a key role in the regulation
of the cell cycle clock (3). Based on the primary sequences,
two distinct families of CDK inhibitors (CKIs) have been
identiﬁed in mammalian cells [for a review, see (4)]. These
families are commonly referred to as CIP/KIP and INK4,
represented by p21
WAF1 (hereafter denoted as p21) and
p16
INK4a (hereafter denoted as p16), respectively. Although
these two CKIs belong to two independent pathways, recent
data have revealed the existence of important interactions
between them, including their binding to the common targets,
CDK4 and CDK6 (4,5). p21 protein is activated in response
to different DNA damaging agents, including ultraviolet
(UV) light and ionizing radiation. Following g-rays, p21
protein is activated in p53-dependent manner (6). On the
other hand, the effect of UV light on p21 protein level is
still puzzling. Several reports have shown that p21 protein
level is up-regulated in response to low UV ﬂuences in
both normal human cell strains (7–10) and mouse embryonic
ﬁbroblasts (11). However, other publications have reported
reduction and ubiquitin-dependent degradation of p21 protein
level following UV irradiation in different cell lines (12–18).
It is noteworthy, however, that most of these studies showing
UV-dependent reduction in p21 level were performed on
cancer cell lines. To shed light on these conﬂicting results,
Itoh and Linn used a human normal primary lung ﬁbroblast
strain (IMR-90), which has been also used by Bendjennat
et al. (12), and showed that p21 protein level is indeed up-
regulated in response to low UV doses (1.2–6 J m
 2)i n
different experimental conditions (19).
Other conﬂicting conclusions regarding UV-dependent p21
induction concern the role of p53 in this process. While
different laboratories have reported that p21 protein as well
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types (7,11,20–22), two papers described p53-dependent
activation of p21 (23,24). These conﬂicting conclusions
indicate that p21 up-regulation in response to UV light is
still unclear and thereby, further studies are required to clarify
this issue.
p16 is a key tumor suppressor that blocks the progression
of the cell cycle by binding to either CDK4 or CDK6 and
inhibiting the action of cyclin D (25–28). The p16 coding
gene has been found homozygously deleted, mutated or
transcriptionally inhibited by methylation in a large number
of different human tumor types (26–29). Furthermore, mice
lacking p16 are tumor prone and develop different types of
cancer, particularly after exposure to carcinogens (30,31).
p16 has been also found to be linked to familial melanoma
and is considered the most important melanoma susceptibi-
lity gene (27,32). Compelling epidemiological and basic
science data support a critical causal role of sunlight exposure
in the development of melanoma (33). However, the func-
tional relationship between p16 and UV radiation in the
pathogenesis of cutaneous malignant melanoma is largely
unknown.
In the present report, we have shown that p21 protein level
increases following low UV ﬂuences in different human
and mouse cell lines, and that this increase is under the con-
trol of p16. We have also shown that the UV-dependent
nucleocytoplasmic shuttling of the HuR protein is under the
control of p16, which led us to suggest that p16 controls
p21 up-regulation by enabling the cytoplasmic accumulation
of HuR.
MATERIALS AND METHODS
Cell lines and cell culture
U2OS, human osteosarcoma cell line, which does not express
endogenous p16 due to hypermethylation, EH1 and EH2,
derived from U2OS, which express p16 under the control
of isopropyl-b-D-thiogalactopyranoside (IPTG)-inducible
promoter (34). (The three cell lines are a generous gift
from Dr G. Peters). The mouse embryo ﬁbroblasts used
were p16 (WT) and their p16-speciﬁc knockout counterpart
(30) (MEF cell lines are a generous gift from Dr R. A.
DePinho). Mouse skin ﬁbroblast cells, p53
+/+ and p53
 / 
were derived, respectively, from B6129F2/J 101045 and
B6129-Trp53
tm1Tyj strains (35). MM470, is a melanoma cell
line (gift from Dr N. Hayward and Dr P. Parsons); MEN1,
meningioma-derived primary cell line (36); HSF1 and
HFSN1 are normal human skin ﬁbroblasts and MCF-12,
‘normal’ epithelial cells (ATCC). These cells were routinely
cultured in DMEM supplemented with 10% CBS.
Irradiation
Cells were grown to conﬂuence in DMEM with supplements.
The medium was removed and the monolayers in dishes were
covered with phosphate-buffered saline (PBS) and exposed to
a germicidal UV lamp (254 nm) at a ﬁxed distance. The UV
dosimetry was performed using an UV meter (Spectronics
Corporation, NY). For g-ray treatment, a Co source was
used at a dose rate of 0.60 Gy/min.
Cellular lysate preparation
Cells were washed and scraped in lysis buffer [150 mM NaCl,
1% Triton X-100 and 50 mM Tris–HCl (pH 7.5)], supplemen-
ted with 40 mg/ml aprotinin, 20 mg/ml leupeptin and 5 mg/ml
pepstatin. Lysates were homogenized using a polytron homo-
genizer and then centrifuged at 14000 r.p.m. in an Eppendorf
microcentrifuge tube for 20 min. The supernatant was
removed, aliquoted and stored at  80 C.
Immunoblotting
SDS–PAGE was performed using 12% separating minigels.
Equal amounts of protein from different samples were placed
in boiling water for 10 min in the presence of SDS gel sample
buffer (0.5 mM Tris (pH 6.8), 10% glycerol, 10% SDS, 5%
2-mercaptoethanol and 1% bromophenol) and electrophoresed
for 2 h at 125 V. After transfer on to polyvinylidene diﬂuor-
ide membrane (PVDF), the membrane was ﬁrst blocked with
5% powdered skimmed milk in PBST (138 mM NaCl,
2.7 mM KCl (pH 7.4) and 0.1% Tween) for 2 h and then
incubated with the appropriate ﬁrst antibody overnight.
Visualization of the second antibody was performed using a
chemiluminescence detection procedure according to the
manufacturer’s protocol (Amersham-Pharmacia Biotech).
Monoclonal antibodies directed against mouse p21 (F5),
mouse p53 (R-19), human p21 (187), p14 (C-18), p16
(50.1), p53 (DO-I), HuR (3A2), b-actin (C-11), a-tubulin
(TU-02) and PCNA (PC10) were purchased from Santa
Cruz (USA).
Analysis of protein half-life
UV-irradiated and non-irradiated conﬂuent cells were treated
with 20 mg/ml cycloheximide (Sigma) for various periods of
time (0–24 h) and then lysed. Cellular extracts from each
time point were subjected to immunobloting using the appro-
priate antibodies. The intensity of the bands was determined
by densitometry.
Analysis of p21 mRNA stability
UV-irradiated and non-irradiated conﬂuent cells were treated
with 5 mg/ml Actinomycin D (Sigma) for various periods of
time (0–6 h) and then total RNA was puriﬁed and used to
quantify p21 mRNA.
siRNA transfection
Speciﬁc p16 siRNA with the sequence (Fw: TACGATA-
CAAGGCTGTTAGAGAG, Rev: TAGAAGGCACAGTCG-
AGG) targeting the p16 exon 1a and a control siRNA
were integrated in a expression vector (GenScript). Stable
transfection was carried out using human dermal ﬁbroblast
nucleofector kit (Amaxa Biosystems) following the protocol
recommended by the manufacturer. Brieﬂy, 95% conﬂuent
HFSN1 cells were passaged 2 days before nucleofection
and 3 mg of p16 siRNA or the control plasmids was electro-
ported into 0.7 · 10
6 cells using amaxa electroporation
instrument. After electroporation, cells were plated in a
6-well plate containing 1 ml of pre-warmed DMEM media
and incubated for 24 h. In the next day, stable transfectant
were selected using DMEM media containing 1.5 mg/ml neo-
mycin. The concentration of neomycin was reduced thereafter
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expression level has been assessed by immunoblotting.
RNA purification and RT–PCR
Total RNA was puriﬁed using the TRI reagent (Sigma)
according to the manufacturer’s instructions. The concentra-
tion of RNA was determined using Gene Quant II, RNA/
DNA calculator (Pharmacia Biotech). Single-stranded
complementary DNA (cDNA) was obtained from reverse
transcription of 1 mg of RNA using RT–PCR kit (BD
Biosciences) and following the manufacturer protocol.
cDNA was then ampliﬁed with 1 U Taq polymerase,
dNTPs (50 mM) and primers (25 pmol each). The mixture
was ﬁrst heated at 94 C for 5 min and then 30 cycles at
94 C for 1 min, 55 C for 1 min and 72 C for 1 min, then
72 C for 10 min. PCR products were seen on 2% agarose
gel electrophoresis stained by ethidium bromide. The respec-
tive primers were: p21: 50-CAGAGGAGGCGCCAAGACA-
G-30 (forward) and 50-CCTGACGGCGGAAAACGC-30
(reverse), and b-actin: 50-CCCAGCACAATGAAGATCAA-
GATCAT-30 (forward) and 50-ATCTGCTGGAAGGTGGA-
CAGCGA-30 (reverse). The intensity of the bands was
determined with the Quantity One program (Bio-Rad) and
was normalized against b-actin.
Immunoprecipitation and detection of p21 mRNA
The immunoprecipiation experiment has been performed as
described previously (37). Brieﬂy, cell lysates were prepared
from conﬂuent cells, and then centrifuged at 10000 g at 4 C.
Subsequently, 200 mg of protein extracts were incubated in
buffer (50 mM Tris (pH 8), 100 mM NaCl, 10% glycerol,
1· protease inhibitors, 5 mM DTT and 2 U/ml RNasin) and
7.5 mg HuR mouse monoclonal antibody (mouse IgG1 was
used as control) was added and mixed at 4 C for 4 h.
Equal volume of protein A agarose was added per immuno-
precipitation and mixed overnight at 4 C. After centrifuga-
tion, the pellet was resuspended in 1 ml TRI reagent used
for RNA extraction. Total RNA was resuspended in 20 ml
DEPC water, heated at 75 C for 5 min and then chilled on
ice. The RT–PCR reactions were performed as described
above.
Subcellular fractionation
Nuclear and cytoplasmic extracts were prepared as previously
described (38).
Fluorescent RT–PCR
Total RNA from cultured cells was prepared by using Trizol.
Single-stranded cDNA were obtained from reverse transcrip-
tion of 3 mg of total RNA using random hexanucleotides as
primer (50 mM), in the presence of dNTP (250 mM), DTT
(10 mM) and M-MLV (10 U/ml), 1 h at 37 C. cDNA was
then ampliﬁed by PCR with Taq polymerase (0.01 U/ml),
dNTP (250 mM) and speciﬁc 6-FAM labeled primers
(10 mM). The mixture was ﬁrst heated at 94 C for 5 min,
and then 20 cycles at 92 C for 30 s, 55 C for 30 s, 70 C
for 30 s, then 72 C for 5 min. PCR products were analyzed
using the ABI genetic analyzer. This approach was used to
quantify the p21 mRNA in different conditions. The primers
used are:p21: 50-6FAM-CTTTCTAGGAGGGAGACAC-30
(forward) and 50-GTTCCGCTGCTAATCAAAG-30 (reverse).
Actin: 50-6FAM-GATCCACATCTGCT-30 (forward) and
50-GACAGGATGCAGAAGGAGAT-30 (reverse).
RESULTS
Low UV fluences up-regulate p21 protein in different
normal human cell lines
To investigate the effect of low UV doses on p21 protein
level, human skin ﬁbroblast cell line (HSF1), normal breast
epithelial cell line (MCF-12) and benign primary menin-
gioma cell line (MEN1) were irradiated with 5 J m
 2 and
reincubabed for different periods of time and then whole
cell extracts were prepared and used for immunoblotting
analysis. Speciﬁc antibodies against p21 and PCNA (used
as internal control) were utilized. p21 level was up-regulated,
following the cellular treatment with this low UV ﬂuence,
reaching 7-fold induction after 12 h in HSF1 cells, and almost
the same level was maintained throughout the subsequent
12 h of incubation (Figure 1A). Similar result was obtained
with the MCF-12 cell line, wherein p21 level reached
6-fold induction 8 h following the treatment, and MEN1
cells that showed a 3.3-fold induction in p21 level 12 h
following the treatment (Figure 1A). These results show
that p21 protein level increases in response to low UVC ﬂu-
ences in different human cell types. It is noteworthy that
similar results were obtained with other human skin ﬁbro-
blast, epithelial and brain tumor cell lines (data not shown).
Low UV fluences do not up-regulate p21 protein
in p16-deficient cell lines
It has been previously reported that p21 protein level does not
increase in response to UV light in the p16-defective U2OS
cell line (12,13). Likewise, when the p16-deleted MM470
skin cancer cell line (39) was treated with 5 J m
 2 of UV
light, p21 protein level did not increase (Figure 1B). In
contrast, the p21 level decreased during the ﬁrst 16 h
(Figure 1B), like in U2OS [Figure 2B and (12,13)]. These
results suggested a potential role for p16 in the up-regulation
of p21 in response to UV light.
p16 controls UV-dependent up-regulation of p21
in human cells
To further investigate the possible role of p16 in UV-
dependent up-regulation of p21, we made use of the U2OS
cell line, which does not express p16 due to promoter methy-
lation, and its derivative cell lines EH1 and EH2, which
contain p16 under the control of IPTG inducible promoter
(34). It is noteworthy, however, that in the absence of
IPTG, EH1 and EH2 cells express a low basal level of p16,
comparable to the low amount detected in early-passage
human diploid ﬁbroblasts for EH1, but almost undetectable
in EH2 (Figure 2A). p16 expression in these cells does not
exert any measurable effect on cellular growth (12,13).
Using immunoblot analysis, we conﬁrmed the lack of p21
up-regulation following the treatment of U2OS cells with
low UV ﬂuence of 5 J m
 2 (Figure 2B). When EH1 cells
were similarly treated, p21 protein level increased reaching
at time 16 h a level 3-fold higher than that in non-treated
Nucleic Acids Research, 2007, Vol. 35, No. 1 225cells (Figure 2B). Figure 2C shows that most of the EH1
cells were in the G0/G1 phase of the cell cycle throughout
the 24 h that followed the irradiation, indicating that p21
up-regulation is not cell cycle-related. Since p53 is known
to be inducible by UV light, we tested this inducibility in
our conditions and cell lines. Figure 2B shows that in contrast
to p21, p53 levels increased in response to UV light in both
U2OS and EH1, indicating that the effect of p16 is speciﬁc
for p21.
Next, we studied the kinetics and the extent of p21 and p53
induction in the EH2 cell strain, wherein p16 expression is
very low. Conﬂuent cells were split into two sub-populations,
one was treated with 1 mM IPTG for 48 h and the other one
was mock-treated, and then cells were irradiated with a UV
Figure 1. Effect of low UVC fluences on p21 protein levels in normal and p16-defective human cell lines. Cells were either mock-treated or irradiated with UV
light (5 J m
 2) and reincubated for different periods of time, as indicated. Thirty mg of extracted proteins were used for western blot analysis. p21 protein fold
induction following UV treatment was determined by normalizing the values against PCNA. (A) p16-proficient cells. (B) p16 defective cell line.
Figure 2. Effect of UV light on p21 and p53 protein levels in U2OS, EH1 and EH2 strains. Cells were mock-treated or challenged with 5 J m
 2, reincubated and
harvested after the indicated time periods for protein purification or FACScan analysis. Thirty microgram of proteins was used for western blot analysis using the
appropriate antibody, as indicated. PCNA and b-actin were used as internal controls. (A) p16 protein basal levels in U2OS, EH1 and EH2. (B) p21 and p53
protein levels following UV irradiation. (C) FACScan analysis of UV-treated EH1 cells. (D) IPTG-treated and non-treated EH2 cells.
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 2. In absence of IPTG, p21 level did not
increase in response to UV-irradiation (Figure 2D). In
contrast to p21, p53 level increased in EH2, like in EH1
(Figure 2B and D). Figure 2D shows also that the IPTG-
treatment increased the level of p16 in EH2 cells. This
increase, which did not have major effect on the distribution
of cells in the different phases of the cell cycle (data not
shown), led to UV-dependent p21 up-regulation. Indeed,
4 h after the treatment p21 level increased and reached a
level 6-fold higher after 24 h (Figure 2D). This indicates
that p16 plays a positive role in UV-dependent p21 protein
up-regulation.
p16 specific siRNA abrogates p21 activation
in response to UV light
To demonstrate the role of p16 in UV-dependent up-
regulation of p21, the CDKN2A gene has been knocked-
down by speciﬁc siRNA in the human skin ﬁbroblast
HFSN1. p16 siRNA was designed to target the p16 speciﬁc
exon 1a and avoiding the p14
ARF message. Cells were
transfected with a vector expressing either p16 siRNA or a
nonspeciﬁc control siRNA, and neomycin resistant clones
were isolated and stable cell lines were established.
Figure 3A shows that p16 protein level decreased >2.5
times in the p16 siRNA-treated cells as compared to their cor-
responding control, however, the p14
ARF protein level was
not affected. These cells were then challenged with 5 J m
 2
and treated as described above. Importantly, the decrease in
p16 level in HFSN1-p16 siRNA cells was accompanied by
an absence of p21 up-regulation in response to UV treatment
(Figure 3B). p21 level rather decreased with time as it was
observed in MM470, U2OS and EH2 cell lines (Figures 1B
and 2B, D). However, p21 protein level increased in UV-
irradiated control cells reaching a level 2.6-fold higher in
16 h subsequent the treatment (Figure 3B and C). In contrast,
the p53 protein levels were up-regulated in both p16-down-
regulated and control cells (Figure 3B), indicating that the
p16-knock down effect is speciﬁc for p21. These results
show that UV-related p21 up-regulation is p16-dependent.
p16 positively controls UV-dependent activation
of p21 in MEF cells
To conﬁrm this important relationship between the two main
CKIs, p16 and p21, and show that its not cell type or species
speciﬁc, use was made of the p16
 /  and their isogenic
normal counterpart p16
+/+ MEFs. These cells (passage 6)
were challenged with a UV ﬂuence of 10 J m
 2, and then
p21 levels were assessed. Figure 4A shows that at passage
6 the level of p21 did not increase in both p16
 /  and
p16
+/+ cells, which is in contrast to what has been described
above for different p16-proﬁcient cell lines (Figures 1–3).
Knowing that p16 levels augment with serial passages (age-
ing) (40) similar experiment was performed, but on MEF
cells at passage 9. Figure 4D shows that p16 expression is
indeed higher in these cells than in those at passage 6, as
previously reported (30). Importantly, at passage 9, the
level of p21 reached 2.6-fold increase 8 h following UV-
treatment and attained 4-fold increase at 24 h (Figure 4B).
On the other hand, the level of the p21 decreased following
UV-irradiation in p16
 /  as observed for the different p16-
defective cell lines (Figures 1–3). This suggested that at
higher passages the level of the p16 protein is elevated and
Figure 3. p16 knock-down by specific siRNA abrogates UV-dependent p21 up-regulation. HFSN1 cells expressing either specific p16 siRNA or a control
sequence were treated as described in Figure 1, and then specific antibodies were used as indicated. (A) Basal p16 protein levels. (B) p21 and p53 protein levels.
(C) Graph depicting p21 and p53 protein levels following UV-treatment of HFSN1 siRNA-control (open symbols) or HFSN1 p16 siRNA cells (dark symbols).
Error bars indicate standard errors.
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this phenomenon is not cell cycle-related, the cell cycle status
of p16
+/+ cells was analyzed by ﬂow cytometry at different
periods of time following UV-treatment. Figure 4C shows
that most of these cells present a 2n DNA content pattern,
indicating that p21 activation following UV-irradiation is
not cell cycle-related. These ﬁndings corroborate the
data obtained in human cells and show the role of p16 in
UV-dependent activation of p21.
To show that the role of p16 in p21-induction is speciﬁc for
UV light, p16
 /  cells were treated with g-rays (5 Gy) and
p21 protein level was assessed at different periods of time.
As expected, p21 level increased 3-fold at 3 h post-irradiation
(Figure 4E). This shows that p21-activation, known to be
mediated through p53, is not p16-dependent in response to
g-rays.
De novo protein synthesis is required for the
p16-dependent induction of p21 following UV radiation
To address the mechanism whereby p16 up-regulates p21
protein levels in response to UV light, we examined the effect
of UVC on p21 half-life. For this, UV-irradiated and mock-
treated HFSN1 cells were incubated in the presence of cyclo-
heximide (20 mg/ml) to inhibit protein synthesis, and then
the relative amounts of p21 and p53 proteins remaining at
various time points after cycloheximide treatment were
assessed following immunoblotting analysis using densitome-
try. Figure 5 shows that while p21 protein basal half-life is
 2 h, p53 basal half life is  1 h. However, following
UV-irradiation p21 protein levels rapidly decreased like in
Figure 4. Effect of UV light and g-rays on p21 protein levels in MEF cells. MEF cells at passage 6 and 9 were either mock-treated or irradiated with UV light
(10 J m
 2 )o rg-rays (5 Gy), reincubated and harvested after the indicated time periods for protein purification or FACScan analysis. Thirty microgram of
proteins was used for western blot analysis using the appropriate antibody, as indicated. (A) Western blot. (B) Graph depicting p21 induction fold. Error bars
indicate standard errors. (C) FACScan analysis of UV-treated p16
+/+ cells. (D) Western blot, level of p16 in different passages. (E) Western blot, p21 protein
level following g-rays in p16
 /  cells.
Figure 5. UV light does not stabilize p21 protein in HFSN1 cells. Cells were
either UV-irradiated (5 J m
 2) or mock-treated, and then reincubated in the
presence of cycloheximide (20 mg/ml). Next, cells were harvested at the
indicated times for protein purification and western blotting. One hundred
microgram of proteins was loaded and appropriate antibodies were used, as
indicated. (A) Western blots. (B) Graph depicting p21 and p53 protein
amounts. Signals were quantitated by densitometry and were normalized
against PCNA, the amount present at time 0 is considered as 100%. Error bars
indicate standard errors.
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UV-treatment did not augment p21 half-life in HFSN1 cells.
Similar results were obtained with the p16-proﬁcient EH1
and p16
+/+ MEF cell lines (data not shown). This shows that
de novo protein synthesis is required for the induction of p21
in response to UV light, indicating that by contrast to p53, the
p16-dependent increase in p21 protein level is not the result of
post-translational modiﬁcations of the p21 protein.
p16 is required for UVC-dependent stabilization
of p21 mRNA
To investigate the mechanism whereby UVC augments p21
protein level and the role of p16 in this process, we studied
the level of p21 mRNA in HFSN1 expressing either the con-
trol siRNA or the p16 siRNA. Cells were challenged with a
UV ﬂuence of 5 J m
 2, and then were reincubated for differ-
ent periods of time. Subsequently, total RNA was puriﬁed
and the amounts of p21 and actin mRNAs were assessed in
both cell strains using RT–PCR technique. In control cells
3-fold increase in p21 mRNA was obtained 12 h subsequent
UV treatment (Figure 6A). In contrast, p21 mRNA did not
change signiﬁcantly during the 24 h of incubation that
followed UV-treatment (Figure 6A). Similar results were
obtained when ﬂuorescent RT–PCR was used to assess the
role of p16 in the activation of p21 mRNA in the U2OS
and EH1 cells (Figure 6B). Comparable results were
previously reported for U2OS cells treated with 15 J m
 2
(13). Together, these data indicate that p16 is required for
the up-regulation of p21 mRNA in response to UV light.
Next, we sought to study the stability of p21 mRNA
following UV-irradiation in both U2OS and EH1 cells
using ﬂuorescent RT–PCR. Both cell lines were treated
with the transcription inhibitor ActD and then either mock-
treated or irradiated with a UV ﬂuence of 5 J m
 2.
Figure 6C shows that p21 mRNA level decreased sharply
in ActD treated U2OS cells, both non-treated and UV-
irradiated, with a p21 mRNA half-life of  70 min. This indi-
cates that UV-irradiation did not stabilize p21 mRNA in
U2OS cell strain. However, a great mRNA stabilization
was observed in UV-irradiated EH1 cells (p21 mRNA half-
life  5 h), compared to the non-irradiated cells (p21
mRNA half-life  2 h) (Figure 6C). Likewise, when p16
was down-regulated using speciﬁc siRNA in the skin ﬁbro-
blast HFSN1 cells, p21 half-life in non-treated and irradiated
cells was  40 and 70 min, respectively (Figure 6D). This
30 min increase in p21 mRNA turnover following UV treat-
ment could be due to the presence of a small amount of p16
(Figures 6D and 3A). On the other hand, UV-irradiation
increased p21 half-life in the control cells from 2 to 4 h
30 min. These results indicate that p16 is required for the
UV-dependent stabilization of p21 mRNA. Figure 6C and
D show also that, even in absence of DNA damage,
Figure 6. UV light stabilizes p21 mRNA in a p16-dependent manner. Cells were either mock-treated or UV-irradiated (5 J m
 2) and then reincubated for
different periods of time. Total mRNA was extracted and the amount of p21 mRNA was assessed using RT–PCR technique and normalized against actin.
(A) Levels of p21 mRNA in UV-treated p16siRNA and control siRNA expressing HFSN1 cells. (B) Levels of p21 mRNA in UV-treated U2OS and EH1 cells.
(C) Levels of p21 mRNA in UV-irradiated and non-irradiated U2OS (circles) and EH1 (triangles), treated with ActD. (D) p21 mRNA levels in UV-irradiated and
non-irradiated HFSN1 cells expressing either p16 siRNA or control siRNA treated with ActD. Error bars indicate standard errors.
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the absence of p16, indicating a role of this protein in the
stabilization of p21 mRNA.
p16 is required for UV-dependent HuR cytoplasmic
localization and binding to p21 mRNA
The HuR protein has been identiﬁed by its ability to bind p21
mRNA. HuR is principally a nuclear protein that becomes
cytoplasmic following UVC radiation and is required for
the stabilization of p21 mRNA (38). Therefore, it is possible
that p16 and HuR proteins participate in UV-dependent p21
stabilization through the same pathway. p16 may also be
directly or indirectly involved in the HuR function or chan-
neling from the nucleus to the cytoplasm in response to
UV-irradiation. To explore these possibilities, we examined
the sub-cellular distribution of the HuR protein in the nuclear
and cytoplasmic extracts of mock-treated and UV-irradiated
(5 J m
 2) p16-knocked down HFSN1 cells and their corre-
sponding control. As previously reported, Figure 7 shows
that HuR is predominantly nuclear, while tubulin is cytoplas-
mic. Following UV-irradiation, HuR protein level starts
increasing in the cytoplasmic fraction 6 h following the treat-
ment and reached a 5.8-fold increase 12 h later. This signiﬁ-
cant increase in the HuR level correlated with the peak of p21
induction (Figure 6A). However, no signiﬁcant change has
been observed in the nuclear fraction (Figure 7). In contrast,
in p16-down-regulated cells, the HuR level decreased 10-fold
in the cytoplasmic fraction, 12 h subsequent UV-treatment
(Figure 7).
Intrerestingly, similar results were obtained when conﬂuent
U2OS and EH1 cells were used. Indeed, following UV treat-
ment (5 J m
 2) the cytoplasmic HuR level increased up to
6.2 times in the p16-proﬁcient EH1 cells, but decreased in
the p16-deﬁcient U2OS cells (Figure 7). This indicates that
the UV-dependent increase in the level of HuR in the cyto-
plasm is under the control of p16.
To further elucidate the role of p16 in the HuR-dependent
stabilization of p21 mRNA following UV light, we studied
the binding of HuR to p21 mRNA following UV-treatment
in p16-defective versus p16-proﬁcient cells. To this end,
U2OS and EH1 were either not treated or UV challenged
with a UV ﬂuence of 5 J m
 2, and then reincubated for
3 and 6 h. Protein lysates were prepared, and then anti-HuR
monoclonal antibody was used to immunoprecipitate HuR.
RNA that coprecipitated with HuR was isolated and used
for RT–PCR reactions using speciﬁc p21 primers. The
house keeping b-actin was also ampliﬁed and used as internal
control. Figure 8 shows that p21 mRNA was associated with
HuR in non-treated cells. Interestingly, the amount of p21
mRNA that coimmunoprecipated with HuR increased
>4 times 6 h after the UV-treatment of EH1 cells. However,
a slight decrease in the coimmunoprecipitated p21 mRNA
occurred in the U2OS cells (Figure 8). This shows that
HuR binding to p21 mRNA following UV light is controlled
by p16 protein.
p16 is required for efficient p53-induction in response
to UV light
It has been recently shown that HuR binds p53 mRNA and
enhances its translation following UV irradiation (41).
Thereby, after showing that the UV-related nuclear/
cytoplasmic relocalization of HuR is under the control of
p16, we asked whether p16 enables efﬁcient p53 induction
following UV light. In fact, we noticed that, although p53
is induced following UV light, this induction is not optimal
in all the p16-defective cell lines as compared to normal
ones (Figures 2 and 3). Next, we studied UV-dependent
p53 up-regulation in MEFs (p16
 /  and p16
+/+) treated as
described above. Figure 9 shows that p53 level increased in
both genotypes, however, not to the same extent. Indeed,
while UV treatment enhanced p53 level 8-fold in p16
+/+
cells, the induction was only 2.7-fold in p16-defective cells
(Figure 9). This shows that p16 knockout attenuated the up-
regulation of p53 protein following UV light.
DISCUSSION
The p21 gene product integrates several extracellular stress
signals into cellular responses that lead to proliferation or
cell cycle arrest (42). These signals are mediated through
different, but overlapping, pathways that are governed by
many proteins. The p21 tumor suppressor protein is activated
in response to different DNA damaging agents and is the
effector of p53 in the ionizing radiation-mediated signaling
route (6). However, the role of p21 and p53 in the UV-
dependent signaling pathway remains elusive. In the present
report, we present evidence that p21 protein is up-regulated in
response to low UV ﬂuences in different mammalian cell
lines that express p16 protein. These include mouse embryo-
nic ﬁbroblasts and mouse skin ﬁbroblasts (p53
 /  and p53
+/+)
and various types of human cells, EH1, two different skin
ﬁbroblasts: HSF1 and HFSN1, MCF-12 (epithelial cells)
and MEN1 (meningioma-derived cell line). In addition, the
IPTG activation of p16 up-regulated p21 in response to UV
light in EH2 cells. On the other hand, p21 protein levels
did not augment following UV light in the cell lines wherein
p16 is defective or down regulated, MEFs, EH2, U2OS,
Figure 7. Effect of p16 on the UV-dependent nucleocytoplasmic shuttling of HuR. Confluent cells were mock- or UV-treated (5 J m
 2) and reincubated for the
indicated periods of time. Cytoplasmic (C) and nuclear (N) cell lysates were prepared and subjected to western blot analysis using the indicated antibodies.
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Collectively, these results clearly show that p21 protein levels
increase in response to low UV ﬂuences, but in a p16-
dependent manner. These data offer further support for
what has been previously reported concerning the up-
regulation of p21 protein in response to UV light (7–11,19),
and suggest that the lack of p21 up-regulation that has been
previously found in different human cell lines could be, at
least is part, due to a defect in p16. In fact, in these studies
several cancer cell lines, including U2OS, were used. For
the human normal primary ﬁbroblast IMR-90 strain, it has
been recently shown that p21 protein increases in response
to low UV ﬂuences using different growing and irradiation
conditions (19). Furthermore, it has been recently shown
that UV induced the level of p21 protein at low ﬂuences,
but reduced its level at higher ﬂuences (43). We have also
found that UV ﬂuences >5Jm
 2 (human cells) and
10 J m
 2 (MEFs) decreases p21 level (data not shown).
Therefore, the decrease in p21 levels following low UV
ﬂuences reported by Bendjennat et al. (12) may have several
reasons, such as UV light calibration and/or the conditions of
UV irradiation (presence/absence of medium) (19) or the
antibody that has been utilized (43).
Furthermore, our data show that p16 protein level is critical
for p21 induction in both human and mouse cells. Indeed, in
the same cell line, cells that express low level of p16 such as
MEF p16
+/+ at passage 6, p21 level did not increase after UV-
treatment. However, when the same cell line reached passage
9 during which the expression of p16 is higher, p21 protein
level increased in response to UV light (Figure 4). Likewise,
no p21 up-regulation was observed in HFSN1-p16 siRNA
and EH2 cells wherein p21 levels are only  2 times lower
than in their corresponding ‘normal’ counterparts, which
showed p21 induction in response to UV damage. This
indicates that p16 level is a critical factor that needs to be
tightly controlled. Indeed, it has been recently shown that a
modest increase in p16 (1.5-fold) had signiﬁcant impact on
cancer resistance (44).
Is p21 up-regulation following UV damage p53-dependent
or not? This is another puzzling question that needs clariﬁca-
tion. We have found that UV damage up-regulates p21 in
mouse skin ﬁbroblasts independently of p53 (data not
shown). Similar results were previously obtained in different
cell lines (7,11,20,21,45). However, two reports described a
p53-dependent activation of p21 (23,24). In these papers,
the p21 basal mRNA levels (24) or the p21 basal protein
levels (23) were much lower in p53-deﬁcient cells than in
p53-proﬁcient ones. However, in both genotypes p21 levels
increased following UV-treatment. Therefore, it seems more
likely that p21 induction in response to UV light is p53-
independent. Therefore, based on the nature of DNA damage,
p21 is activated either through p53 (ionizing radiation), or in
a p16-dependent manner (UV light). This may suggest that
p21 acts as an effector of p16 in the cellular response to
UV damage, while it acts under the control of p53 following
g-rays. In fact, in response to UV light, both p21 and p16 act
as antiapoptosis factors (13,46). Furthermore, p16- and p21-
defective cell lines do not display UV-dependent cell cycle
arrest at G1 phase (12,13,47–49) and are sensitive to UV-
irradiation (50,51). Moreover, it has been previously found
that p21 is required for efﬁcient p16-mediated cell
cycle arrest in HCT116 cells (5). Together, these results
indicate a functional relationship between p16 and p21 during
the cellular response to UV damage.
Evidence presented herein shows also that p16-dependent
activation of p21 following UV light occurs by post-
transcriptional stabilization of p21 mRNA (Figure 6), but
not from post-translational modiﬁcations (Figure 5). These
results are in keeping with the previously reported data show-
ing that the elevation of p21 expression by UVC is mediated
through mRNA stabilization in both MEFs and human color-
ectal carcinoma cells (24). This stabilization requires the
nuclear HuR protein that accumulates in the cytoplasm
following UVC radiation (38). We have shown here that
the increase in the HuR cytoplasmic abundance and its bind-
ing to p21 mRNA in response to UV light are under the
control of p16 (Figures 7 and 8). Accordingly, we are led
to conclude that p16 controls UV-related p21 induction by
regulating the nucleo-cytoplasmic translocation of the
mRNA binding HuR protein. If this is the case, p16 should
also be important for UV-dependent up-regulation of p53
protein, since HuR enhances p53 translation following UV
(41). Indeed, we have found that p16 is required for efﬁcient
p53 induction following UV light (Figure 9). In addition, in
response to UV damage, HuR stabilizes the mRNA of the
gene coding for the small GTP binding RhoB protein (37).
This indicates that HuR play important roles in the cellular
response to UV light.
In conclusion, the data presented in the present report
vividly show that low UVC ﬂuences up-regulate p21 protein
in different mammalian cells, and that this induction is under
the control of the other important CDK inhibitor and tumor
suppressor p16 protein. Moreover, it is shown here that p16
controls also the UV-dependent cytoplasmic accumulation
Figure 8. Role of p16 in the UV-dependent binding of HuR to p21 mRNA.
Confluent cells were mock- or UV-treated (5 J m
 2) and reincubated for the
indicated periods of time. Cell lysates were immunoprecipitaed with HuR
mouse monoclonal antibody and mouse IgG1. Coprecipitated RNA was
purified and used for RT–PCR reactions.
Figure 9. Effect of p16 on the UV-dependent p53 up-regulation in MEF cells.
Cells were treated as described in Figure 4 and western blots using the
indicated antibodies were performed.
Nucleic Acids Research, 2007, Vol. 35, No. 1 231of the mRNA binding HuR protein, which is required for p21
induction, suggesting an indirect effect of p16 on the UV-
mediated p21 mRNA stability through the HuR protein.
Since HuR has a broad post-transcriptional function, we
assume that p16 has major roles in the cellular response to
the carcinogenic UV light, the most important etiological
cause of skin cancer.
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